Indiana-based pharmaceutical company Eli Lilly is facing product liability lawsuits in relation to their diabetes drug, Mounjaro. The medication, along with similar drugs Ozempic and Wegovy, has gained popularity for weight loss and management in obese patients. However, new evidence suggests that higher doses of Mounjaro used for weight loss can lead to serious health problems involving the gallbladder and gastrointestinal system. Users of Mounjaro have reported complications such as gallbladder disease, gallstones, gastroparesis (stomach paralysis), and other stomach conditions.
It has been alleged that Eli Lilly was aware of these risks associated with Mounjaro but failed to warn doctors and patients. As a result, individuals who have experienced these injuries after using Mounjaro are now seeking legal action. National mass tort lawyers at Miller & Zois are currently investigating these cases. If you have taken Mounjaro for weight loss and suffered from gallbladder or gastrointestinal problems, they encourage you to reach out for a free case evaluation.
The growing number of lawsuits surrounding Mounjaro highlight the issue of failure to warn. Plaintiffs claim that Eli Lilly knew or should have known that the use of Mounjaro at higher doses could result in health issues such as gastroparesis or gallbladder disease. However, the drug label for Mounjaro did not include any warnings regarding these specific risks. This lack of information left doctors and patients unaware of the potential dangers associated with the medication.
While there is currently no class action lawsuit or multidistrict litigation (MDL) for Mounjaro, it is possible that these cases may be consolidated into a class action MDL in the future. A similar consolidation occurred recently for lawsuits involving Ozempic, a drug similar to Mounjaro. If a new Mounjaro class action MDL is established, all pending lawsuits nationwide will be combined and overseen by a single judge. This consolidation will allow for a collective discovery phase, followed by bellwether trials to gauge potential outcomes and facilitate negotiations for a global settlement.
As for potential settlement amounts in Mounjaro lawsuits, it is difficult to provide an accurate estimate at this stage. The scientific evidence behind these cases must be thoroughly examined to determine their validity. However, based on speculative assumptions, it is believed that a successful Mounjaro lawsuit could result in a settlement ranging from $150,000 to $300,000. This estimate is lower than the value estimate for Ozempic lawsuits due to the shorter time Mounjaro has been on the market, resulting in less exposure for plaintiffs.
If you believe you have been harmed by Mounjaro and are considering filing a lawsuit, it is crucial to seek legal representation. Contacting experienced lawyers, such as those at Miller & Zois, can provide guidance and support throughout the process. Call 800-553-8082 or visit their website to get in touch with their team.